Peptide-based proteasome inhibitors in anticancer drug design.
about
Pseudopeptidic compounds for the generation of dynamic combinatorial libraries of chemically diverse macrocycles in aqueous media.Noncovalent inhibitors of human 20S and 26S proteasome based on trypsin inhibitor SFTI-1.Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors.Vinylboronic Acids as Efficient Bioorthogonal Reactants for Tetrazine Labeling in Living Cells.NMR conformational analysis in solution of a potent class of cysteine proteases inhibitors
P2860
Peptide-based proteasome inhibitors in anticancer drug design.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Peptide-based proteasome inhibitors in anticancer drug design.
@en
type
label
Peptide-based proteasome inhibitors in anticancer drug design.
@en
prefLabel
Peptide-based proteasome inhibitors in anticancer drug design.
@en
P2860
P50
P356
P1476
Peptide-based proteasome inhibitors in anticancer drug design
@en
P2093
Kety Scarbaci
Valeria Troiano
P2860
P304
P356
10.1002/MED.21312
P577
2014-03-01T00:00:00Z